Brain Cancer Global Clinical Trials Review, Q4, 2010

Date: December 1, 2010
Pages: 89
Price:
US$ 1,000.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B85BBAB271BEN
Leaflet:

Download PDF Leaflet

Brain Cancer Global Clinical Trials Review, Q4, 2010
Brain Cancer Global Clinical Trials Review, Q4, 2010

Summary

GlobalData's clinical trial report, “Brain Cancer Global Clinical Trials Review, Q4, 2010” provides data on the Brain Cancer clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Brain Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Brain Cancer).

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope
  • Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
  • Review of key discontinued trials (suspended, withdrawn and terminated)
  • Overview of the enrollment pattern by phase for the past decade
  • Number of clinical trials segmented by key drugs
  • Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
  • Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others

Reasons to buy
  • Understand the dynamics of a particular indication as a whole
  • Examine the performance of the trials in terms of their status, recruitment, success rates and others
  • Obtain discontinued trial information for trials across the globe
  • Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
List of Tables
List of Figures
Introduction
Brain Cancer
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Brain Cancer
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Brain Cancer Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Alberta Health Services
Clinical Trial Overview of Alberta Health Services
Neopharm Ltd.
Clinical Trial Overview of Neopharm Ltd.
Barrett Cancer Center
Clinical Trial Overview of Barrett Cancer Center
Novartis AG
Clinical Trial Overview of Novartis AG
Direct Therapeutics, Inc.
Clinical Trial Overview of Direct Therapeutics, Inc.
Celtic Pharmaceutical Holdings L.P.
Clinical Trial Overview of Celtic Pharmaceutical Holdings L.P.
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
BTG plc
Clinical Trial Overview of BTG plc
Advocate Health Care
Clinical Trial Overview of Advocate Health Care
Neurocrine Biosciences, Inc.
Clinical Trial Overview of Neurocrine Biosciences, Inc.
Aposense Ltd.
Clinical Trial Overview of Aposense Ltd.
MediGene AG
Clinical Trial Overview of MediGene AG
YM BioSciences Inc.
Clinical Trial Overview of YM BioSciences Inc.
SkyePharma PLC
Clinical Trial Overview of SkyePharma PLC
Grifols, S.A.
Clinical Trial Overview of Grifols, S.A.
Nexstim Oy
Clinical Trial Overview of Nexstim Oy
Hoffmann-La Roche Inc.
Clinical Trial Overview of Hoffmann-La Roche Inc.
medac GmbH
Clinical Trial Overview of medac GmbH
Clinical Trial Overview of Top Universities / Institutes / Hospitals
National Cancer Institute (NCI)
Clinical Trial Overview of National Cancer Institute (NCI)
Duke University
Clinical Trial Overview of Duke University
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
European Organization for Research and Treatment of Cancer
Clinical Trial Overview of European Organization for Research and Treatment of Cancer
North Central Cancer Treatment Group
Clinical Trial Overview of North Central Cancer Treatment Group
Stanford University
Clinical Trial Overview of Stanford University
Burzynski Research Institute, Inc.
Clinical Trial Overview of Burzynski Research Institute, Inc.
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
St. Jude Children’s Research Hospital, Inc.
Clinical Trial Overview of St. Jude Children’s Research Hospital, Inc.
Case Comprehensive Cancer Center
Clinical Trial Overview of Case Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
University of California, Los Angeles
Clinical Trial Overview of University of California, Los Angeles
Oregon Health and Science University
Clinical Trial Overview of Oregon Health and Science University
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
New York University School of Medicine
Clinical Trial Overview of New York University School of Medicine
Wake Forest University
Clinical Trial Overview of Wake Forest University
UCLA's Jonsson Comprehensive Cancer Center
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Clinical Trial Overview of Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Masonic Cancer Center
Clinical Trial Overview of Masonic Cancer Center
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Brain Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2010*
Brain Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2010*
Brain Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2010*
Brain Cancer Therapeutics Clinical Trials, Asia-Pacific , Top Five Countries, 2010*
Brain Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2010*
Brain Cancer Therapeutics Clinical Trials, North America, Top Countries, 2010*
Brain Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2010*
Brain Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2010*
Brain Cancer Therapeutics Clinical Trials, BRIC Countries, 2010*
Brain Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2010*
Brain Cancer Therapeutics Market, Global, Clinical Trials in Progress by Phase 2010*
Brain Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2010*
Brain Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2010*
Brain Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2010*
Brain Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2010*
Brain Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Brain Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2010*
Brain Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010*
Brain Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Schering-Plough Corporation (Inactive), 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Health Services, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Neopharm Ltd., 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Barrett Cancer Center, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Direct Therapeutics, Inc., 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celtic Pharmaceutical Holdings L.P., 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Pharmaceuticals, LP, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Protherics PLC (Inactive), 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Advocate Health Care, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurocrine Biosciences, Inc., 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Aposense Ltd., 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by MediGene AG, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by YM BioSciences Inc., 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by SkyePharma PLC, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Nexstim Oy, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Hoffmann-La Roche Inc., 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by medac GmbH, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute (NCI), 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by North Central Cancer Treatment Group, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Burzynski Research Institute, Inc., 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children’s Research Hospital, Inc., 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 2010*
Brain Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2010* 85

LIST OF FIGURES

Brain Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2010*
Brain Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2010*
Brain Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2010*
Brain Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2010*
Brain Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2010*
Brain Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2010*
Brain Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2010*
Brain Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2010*
Brain Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2010*
Brain Cancer Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2010*
Brain Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2010*
Brain Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Brain Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2010*
Brain Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010*
Brain Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2010*
GlobalData Methodology 87
Brain Cancer Global Clinical Trials Review, H2, 2011 US$ 1,000.00 Aug, 2011 · 120 pages
Penile Cancer Global Clinical Trials Review, Q4, 2010 US$ 1,000.00 Dec, 2010 · 29 pages
Bladder Cancer Global Clinical Trials Review, H2, 2011 US$ 1,000.00 Aug, 2011 · 119 pages
Bone Cancer Global Clinical Trials Review, H2, 2011 US$ 1,000.00 Aug, 2011 · 109 pages

Ask Your Question

Brain Cancer Global Clinical Trials Review, Q4, 2010
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: